TOLLIP and triple-negative breast carcinoma: In triple-negative breast cancer, TOLLIP-mediated autophagy can hinder disease progression via the degradation of transmembrane protein 63A (TMEM63A), a novel oncogene that promotes cancer cell proliferation in triple-negative breast cancer [35].